top of page
Couple
SugaHeal Logo.png

OVERVIEW

SUGAHEAL® is an innovative, natural and clinically tested ingredient derived from Fenugreek seed shown to be effective in supporting healthy blood glucose levels and HbAlC in Type 2 diabetes.

To use these best in class Raw Ingredients in your masterpieces, Call Dr. Tim Harrigan at (520) 395-5156 or e-mail our team: Info@SynWellness.com​

KEY FEATURES

  • Wake gout DNA authenticated

  • 100% naturally extracted ingredient

  • Allergen free and Vegan

  • Gluten Free, NON-GMO project verified

  • HALAL and Kosher certified

  • GRAS affirmed in USA

  • ETO Compliant

  • California prop 65 compliant for Heavy Metals

  • Safety established through toxicological studies

Health Claims

HELPS MAINTAIN
GLYCATED HAEMOGLOBIN LEVELS (HBAIC) IN THE OPTIMUM RANGE

HELPS IN ACHIEVING BETTER GLYCAEMIC CONTROL

LEADS TO REQUIRING FEWER INSULIN DOSES
NEEDED PER DAY

RESULTS IN EXPERIENCING FEWER HYPOGLYCAEMIC
EVENTS PER DAY

SCIENTIFIC STUDY

Pre-Clinical

Screenshot 2025-08-17 at 11.59.16 AM.png

Clinical

Screenshot 2025-08-17 at 12.03.41 PM.png
Screenshot 2025-08-17 at 12.03.57 PM.png

CERTIFICATION

Screenshot 2025-08-17 at 10.39.56 AM.png
Screenshot 2025-08-17 at 10.40.08 AM.png
Screenshot 2025-08-17 at 10.40.12 AM.png
Screenshot 2025-08-17 at 10.40.22 AM.png
Screenshot 2025-08-17 at 10.40.29 AM.png
Screenshot 2025-08-17 at 10.40.35 AM.png
Screenshot 2025-08-17 at 10.40.43 AM.png

REFERENCES

1. ARORA, S., S. L. BODHANKAR, V. MOHAN AND P. A. THAKURDESAI (2012). "RENOPROTECTIVE EFFECTS OF RECONSTRUCTED COMPOSITION OF TRIGONELLA FOENUM-GRAECUM L. SEEDS IN ANIMAL MODEL OF DIABETIC NEPHROPATHY WITH AND WITHOUT RENAL ISCHEMIA REPERFUSION IN RATS." INTERNATIONAL JOURNAL OF PHARMACOLOGY 8(5): 321-332.
2. DUTTA, M., A. K. GHOSH, V. MOHAN, P. MISHRA, V. RANGARI, A. CHATTOPADHYAY, T. DAS, D. BHOWMICK AND D.
BANDYOPADHYAY (2014). "ANTIOXIDANT MECHANISM (S) OF PROTECTIVE EFFECTS OF FENUGREEK 4-HYDROXYISOLEUCINE AND TRIGONELLINE ENRICHED FRACTION (TF4H (28%)) SUGAHEAL AGAINST COPPER-ASCORBATE
INDUCED INJURY TO GOAT CARDIAC MITOCHONDRIA IN VITRO." J PHARM RES 8(6): 798-811.
3. KANDHARE, A., S. BODHANKAR, V. MOHAN AND P. THAKURDESAI (2015). THERAPEUTIC POTENTIAL OF SYNERGISTIC COMPOSITION FROM FENUGREEK SEEDS (SUGAHEAL®) AGAINST NONALCOHOLIC STEATOHEPATITIS IN C57BL/6 MICE. 2ND INTERNATIONAL CONGRESS OF SOCIETY FOR ETHNOPHARMACOLOGY (SFEC - 2015) NAGPUR, SOCIETY FOR ETHNOPHARMACOLOGY
4. KANDHARE, A., U. PHADKE, A. MANE, P. THAKURDESAI AND S. BHASKARAN (2018). "ADD-ON THERAPY OF HERBAL FORMULATION RICH IN STANDARDIZED FENUGREEK SEED EXTRACT IN TYPE 2 DIABETES MELLITUS PATIENTS WITH INSULIN THERAPY: AN EFFICACY AND SAFETY STUDY." ASIAN PACIFIC JOURNAL OF TROPICAL BIOMEDICINE 8(9): 446-455.
5. KANDHARE, A. D., N. RAIS, N. MOULICK, A. DESHPANDE, P. THAKURDESAI AND S. BHASKARAN (2018). "EFFICACY AND SAFETY OF HERBAL FORMULATION RICH IN STANDARDIZED FENUGREEK SEED EXTRACT AS ADD-ON SUPPLEMENTATION IN PATIENTS WITH TYPE 2 DIABETES MELLITUS ON SULFONYLUREA THERAPY: A 12-WEEK, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTI-CENTER STUDY." PHARMACOGNOSY MAGAZINE 14(57): 393-402.
6. KULKARNI, C. P., S. L. BODHANKAR, A. E. GHULE, V. MOHAN AND P. A. THAKURDESAI (2012). "ANTIDIABETIC ACTIVITY OF TRIGONELLA FOENUMGRAECUM L. SEEDS EXTRACT (IND01) IN NEONATAL STREPTOZOTOCIN-INDUCED (N-STZ) RATS." DIABETOLOGIA CROATICA 41(1).
7. MORANI, A. S., S. L. BODHANKAR, V. MOHAN AND P. A. THAKURDESAI (2012). "AMELIORATIVE EFFECTS OF STANDARDIZED EXTRACT FROM TRIGONELLA FOENUM-GRAECUM L. SEEDS ON PAINFUL PERIPHERAL NEUROPATHY IN RATS." ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE 5(5): 385-390.
8. SHITOLE, P. P., S. L. BADOLE, S. L. BODHANKAR, M. V. MV AND S. BHASKARAN (2009). "ANTI-HYPERGLYCAEMIC ACTIVITY OF IND 01 AND ITS INTERACTION WITH GLYBURIDE AND PIOGLITAZONE IN ALLOXAN INDUCED DIABETIC MICE." DUBAI DIABETES AND ENDOCRINOLOGY JOURNAL 17(1): 21-26.
9. THAKURDESAI, P., V. MOHAN AND A. KANDHARE (2015). SYNERGISTIC COMPOSITION OF FENUGREEK SEED EXTRACT (SUGAHEAL®) AMELIORATES HIGH-FAT DIET-INDUCED INSULIN RESISTANCE IN C57BL/6 MICE VIA MODULATING THE EXPRESSION OF LEPTIN, GLUT-2, GLUT-4, IRS-2 AND SREBP-IC. 2ND INTERNATIONAL CONFERENCE ON BIOTECHNOLOGY AND BIOINFORMATICS (ICBB-2015), PUNE, INDIA, INTERNATIONAL CENTER FOR STEM CELLS, CANCER AND BIOTECHNOLOGY (ICSCCB), PUNE.

*Disclaimer: These statements have not been evaluated by the food and drug administration.

This product is not intended to diagnose, treat, cure, or prevent any disease.

bottom of page